<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.3: Cytochrome P450 Enzymes: The Science of Drug Metabolism</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Herbalism Safety */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Table Styling */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f1f5f9;
            padding: 15px;
            font-weight: 700;
            color: #1e3a8a;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 2px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e3a8a;
            margin-top: 0;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: Clinical Safety & Toxicology</p>
            <h1 class="lesson-title">Lesson 11.3: Cytochrome P450 Enzymes: The Science of Drug Metabolism</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Hepatic Powerhouse</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Phase I: The Oxidation Mechanism</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The "Big Three" CYP Enzymes</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Induction vs. Inhibition</a></li>
                <li><a href="#section5"><span class="section-num">5</span>High-Risk Herbal Interactions</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Prodrug Trap</a></li>
                <li><a href="#section7"><span class="section-num">7</span>V.I.T.A.L. Method Safety Screening</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the physiological role of the Cytochrome P450 (CYP450) enzyme superfamily in drug biotransformation.</li>
                <li>Differentiate between <span class="highlight">enzyme induction</span> and <span class="highlight">enzyme inhibition</span> and their clinical consequences.</li>
                <li>Identify the primary CYP enzymes responsible for the metabolism of over 90% of pharmaceutical agents.</li>
                <li>Analyze how specific botanicals, such as St. Johnâ€™s Wort and Goldenseal, alter the metabolic clearance of medications.</li>
                <li>Apply the V.I.T.A.L. Methodâ„¢ to perform a rigorous toxicological screening for poly-pharmacy clients.</li>
            </ul>
        </div>

        <h2 id="section1">The Hepatic Powerhouse</h2>
        <p>In the realm of clinical herbalism, the liver is the primary gatekeeper of safety. Within the hepatocytes (liver cells) and the enterocytes of the small intestine lies a massive superfamily of heme-containing proteins known as <span class="highlight">Cytochrome P450 (CYP450)</span>. These enzymes are the primary drivers of Phase I metabolism, responsible for the biotransformation of endogenous compounds (like steroid hormones and bile acids) and exogenous substances (xenobiotics), including both pharmaceutical drugs and herbal constituents.</p>

        <p>The "450" in the name refers to the peak absorption wavelength of the enzyme when bound to carbon monoxide (450 nanometers). While there are 57 identified CYP genes in humans, only a small handful are responsible for the vast majority of drug metabolism. Understanding these enzymes is not just academic; it is the cornerstone of the <span class="highlight">Toxicological & Safety Screening (T)</span> step of the V.I.T.A.L. Methodâ„¢.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Drugs via CYP3A4</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">57</div>
                    <div class="stat-label">Human CYP Genes</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">Total Drug Metabolism</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">Liver Protein Content</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Phase I: The Oxidation Mechanism</h2>
        <p>Biotransformation typically occurs in two phases. <span class="highlight">Phase I metabolism</span> involves the modification of a molecule through oxidation, reduction, or hydrolysis. The goal is to make a lipophilic (fat-soluble) compound more hydrophilic (water-soluble) so it can eventually be excreted by the kidneys or bile.</p>

        <p>CYP450 enzymes primarily catalyze <span class="highlight">oxidation</span>. By inserting an oxygen atom into the substrate, the enzyme creates a "handle" (often a hydroxyl group) that allows Phase II enzymes to attach a larger, water-soluble molecule (like glucuronic acid or glutathione). However, this Phase I process can sometimes create "reactive intermediates"â€”metabolites that are more toxic than the original substance. This is why supporting both phases of detoxification is critical in herbal protocols.</p>

        <h2 id="section3">The "Big Three" CYP Enzymes</h2>
        <p>While the CYP family is diverse, clinical practitioners must focus on three specific enzymes that handle the lion's share of interactions:</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Enzyme</th>
                        <th>% of Drug Metabolism</th>
                        <th>Common Drug Substrates</th>
                        <th>Key Herbal Interactors</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>CYP3A4</strong></td>
                        <td>40% - 50%</td>
                        <td>Statins, CCBs, Cyclosporine, HIV Protease Inhibitors</td>
                        <td>St. John's Wort (Inducer), Grapefruit (Inhibitor)</td>
                    </tr>
                    <tr>
                        <td><strong>CYP2D6</strong></td>
                        <td>20% - 25%</td>
                        <td>Antidepressants (SSRIs), Beta-blockers, Codeine (Prodrug)</td>
                        <td>Goldenseal (Inhibitor), Black Cohosh (Weak)</td>
                    </tr>
                    <tr>
                        <td><strong>CYP2C9</strong></td>
                        <td>10% - 15%</td>
                        <td>Warfarin, NSAIDs, Sulfonylureas</td>
                        <td>Garlic (Potential), Ginkgo (Weak)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">Induction vs. Inhibition</h2>
        <p>This is the most critical concept for the safety-conscious practitioner. Herbal constituents can change the "speed" at which these enzymes work, leading to two distinct types of Herb-Drug Interactions (HDIs).</p>

        <h3>1. Enzyme Inhibition (The "Traffic Jam")</h3>
        <p>Inhibition occurs when a herbal constituent binds to the CYP enzyme, preventing it from processing the drug. This results in <span class="highlight">elevated serum levels</span> of the drug, significantly increasing the risk of toxicity. For example, the furanocoumarins in grapefruit juice inhibit intestinal CYP3A4, which can lead to a 300% increase in the bioavailability of certain statins, potentially causing rhabdomyolysis.</p>

        <h3>2. Enzyme Induction (The "Fast Lane")</h3>
        <p>Induction occurs when a herb stimulates the body to produce *more* enzyme. This increases the rate of drug clearance, leading to <span class="highlight">sub-therapeutic serum levels</span>. This is often more dangerous than it sounds, as it can lead to "therapeutic failure"â€”for example, the failure of an organ transplant or an unintended pregnancy due to reduced contraceptive efficacy.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Transplant Crisis</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">St. John's Wort and Cyclosporine</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">ðŸ‘¨</div>
                    <div class="patient-info">
                        <h4>Patient: David R., 52</h4>
                        <p>Post-renal transplant patient on Cyclosporine (immunosuppressant).</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> David began self-prescribing 900mg of St. Johnâ€™s Wort (SJW) daily to manage mild post-surgical depression. Within three weeks, his routine blood work showed a 60% drop in serum cyclosporine levels, falling well below the therapeutic window.</p>
                <p><strong>Mechanism:</strong> SJW contains hyperforin, a potent ligand for the <span class="highlight">Pregnane X Receptor (PXR)</span>. Activation of PXR induces a massive upregulation of CYP3A4 and P-glycoprotein (an efflux pump).</p>
                <p><strong>Outcome:</strong> David experienced acute organ rejection symptoms. SJW was immediately discontinued, and cyclosporine levels were stabilized, but permanent graft damage occurred. This case highlights why SJW is contraindicated with narrow-therapeutic-index drugs.</p>
            </div>
        </div>

        <h2 id="section5">High-Risk Herbal Interactions</h2>
        <p>A 2022 systematic review of clinical trials (n=142) identified several herbs with high potential for clinical significance via the CYP pathway:</p>
        
        <ul class="content-list">
            <li><strong>Goldenseal (Hydrastis canadensis):</strong> One of the most potent inhibitors of CYP3A4 and CYP2D6 in humans. In clinical studies, Goldenseal reduced CYP3A4 activity by approximately 40%, comparable to pharmaceutical inhibitors.</li>
            <li><strong>St. Johnâ€™s Wort (Hypericum perforatum):</strong> The "gold standard" for enzyme induction. It affects CYP3A4, CYP2C9, and CYP1A2. Its effects can persist for up to 14 days after the last dose due to the time required for new enzyme synthesis.</li>
            <li><strong>Schisandra (Schisandra chinensis):</strong> Recent studies show Schisandra can inhibit CYP3A4 in the short term, but chronic use may actually induce it. This "biphasic" effect makes it difficult to predict in a clinical setting.</li>
            <li><strong>Green Tea (Camellia sinensis):</strong> High doses of EGCG have been shown to weakly inhibit CYP3A4, though dietary consumption is generally considered safe.</li>
        </ul>

        <h2 id="section6">The Prodrug Trap</h2>
        <p>Practitioners must be particularly wary of <span class="highlight">prodrugs</span>â€”medications that are inactive when swallowed and must be converted by CYP enzymes into their active forms. If an herb inhibits the enzyme responsible for this conversion, the patient will receive no therapeutic benefit from the drug.</p>

        <p>A classic example is <strong>Codeine</strong>. Codeine is a prodrug that must be converted by <span class="highlight">CYP2D6</span> into morphine to provide pain relief. If a client is taking a potent CYP2D6 inhibitor (like Goldenseal or even certain SSRIs), the codeine will never become morphine, and the client will remain in pain despite taking the medication. Conversely, an "ultra-rapid metabolizer" might convert it too quickly, leading to morphine toxicity.</p>

        <h2 id="section7">V.I.T.A.L. Method Safety Screening</h2>
        <p>In the V.I.T.A.L. Methodâ„¢, the <strong>Toxicological & Safety Screening (T)</strong> is non-negotiable. As a practitioner, your workflow should follow this clinical logic:</p>

        <div class="principle-card">
            <p class="principle-title">Step 1: Medication Reconciliation</p>
            <p class="principle-text">Identify every pharmaceutical and supplement the client is taking. Use a database (like Stockleyâ€™s Herbal Medicines Interactions) to identify which CYP enzymes metabolize those drugs.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">Step 2: Narrow Therapeutic Index (NTI) Check</p>
            <p class="principle-text">Is the drug an NTI drug? (e.g., Warfarin, Digoxin, Lithium, Cyclosporine, Phenytoin). If yes, avoid any herb with even moderate CYP influence.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">Step 3: Metabolic Profile Match</p>
            <p class="principle-text">Cross-reference the client's herbal protocol with their drug list. If a client is on a CYP3A4 substrate, avoid CYP3A4 inducers (SJW) and potent inhibitors (Goldenseal).</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of CYP450 mechanisms</p>

            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">If a client is taking a statin (a CYP3A4 substrate) and starts taking a potent CYP3A4 <strong>inhibitor</strong> like Goldenseal, what is the likely clinical outcome?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The serum levels of the statin will increase because the enzyme responsible for its clearance is being blocked. This increases the risk of side effects like muscle pain or liver enzyme elevation.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Why does the induction effect of St. John's Wort last for several days even after the herb is discontinued?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Induction involves the synthesis of new enzyme proteins. Even after the herb is gone, those extra enzymes remain in the liver until they reach the end of their natural lifespan and are degraded by the body, which can take 1-2 weeks.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>CYP450 enzymes are the primary drivers of Phase I drug metabolism in the liver and gut.</li>
                <li><strong>CYP3A4</strong> is the most critical enzyme, metabolizing roughly 50% of all pharmaceuticals.</li>
                <li><strong>Inhibition</strong> leads to drug toxicity; <strong>Induction</strong> leads to therapeutic failure.</li>
                <li>St. John's Wort is a potent inducer, while Goldenseal is a potent inhibitor.</li>
                <li>Always screen for "Prodrugs" where inhibition can lead to a total loss of drug efficacy.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>1. Dresser et al. (2021). "Herbal Medicine-Drug Interactions: A Systematic Review of Clinical Evidence." <i>Journal of Clinical Pharmacology.</i></p>
            <p>2. Gurley et al. (2012). "In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes." <i>Clinical Pharmacology & Therapeutics.</i></p>
            <p>3. Moore et al. (2000). "St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor." <i>Proceedings of the National Academy of Sciences (PNAS).</i></p>
            <p>4. Wanwimolruk et al. (2014). "Cytochrome P450 enzyme-mediated herbal drug interactions (part 1)." <i>EXCLI Journal.</i></p>
            <p>5. FDA (2020). "Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers." <i>Clinical Guidelines.</i></p>
            <p>6. Hermann et al. (2023). "Mechanisms of Herb-Induced Liver Injury and Metabolic Interactions." <i>Toxicology Letters.</i></p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Herbalism Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Confidential Professional Training Material.</p>
        </footer>
    </div>
</body>

</html>